1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global CIS Insulin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Long-Acting Analog 1.2.3 Rapid Acting Analog 1.2.4 Premixed Analog 1.2.5 Intermediate Insulin 1.2.6 Short Acting Insulin 1.2.7 Premixed Insulin 1.3 Market by Application 1.3.1 Global CIS Insulin Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Type I and Other Diabetes 1.3.3 Type II Diabetes 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global CIS Insulin Market Perspective (2016-2027) 2.2 CIS Insulin Growth Trends by Regions 2.2.1 CIS Insulin Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 CIS Insulin Historic Market Share by Regions (2016-2021) 2.2.3 CIS Insulin Forecasted Market Size by Regions (2022-2027) 2.3 CIS Insulin Industry Dynamic 2.3.1 CIS Insulin Market Trends 2.3.2 CIS Insulin Market Drivers 2.3.3 CIS Insulin Market Challenges 2.3.4 CIS Insulin Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top CIS Insulin Players by Revenue 3.1.1 Global Top CIS Insulin Players by Revenue (2016-2021) 3.1.2 Global CIS Insulin Revenue Market Share by Players (2016-2021) 3.2 Global CIS Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by CIS Insulin Revenue 3.4 Global CIS Insulin Market Concentration Ratio 3.4.1 Global CIS Insulin Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by CIS Insulin Revenue in 2020 3.5 CIS Insulin Key Players Head office and Area Served 3.6 Key Players CIS Insulin Product Solution and Service 3.7 Date of Enter into CIS Insulin Market 3.8 Mergers & Acquisitions, Expansion Plans 4 CIS Insulin Breakdown Data by Type 4.1 Global CIS Insulin Historic Market Size by Type (2016-2021) 4.2 Global CIS Insulin Forecasted Market Size by Type (2022-2027) 5 CIS Insulin Breakdown Data by Application 5.1 Global CIS Insulin Historic Market Size by Application (2016-2021) 5.2 Global CIS Insulin Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America CIS Insulin Market Size (2016-2027) 6.2 North America CIS Insulin Market Size by Type 6.2.1 North America CIS Insulin Market Size by Type (2016-2021) 6.2.2 North America CIS Insulin Market Size by Type (2022-2027) 6.2.3 North America CIS Insulin Market Size by Type (2016-2027) 6.3 North America CIS Insulin Market Size by Application 6.3.1 North America CIS Insulin Market Size by Application (2016-2021) 6.3.2 North America CIS Insulin Market Size by Application (2022-2027) 6.3.3 North America CIS Insulin Market Size by Application (2016-2027) 6.4 North America CIS Insulin Market Size by Country 6.4.1 North America CIS Insulin Market Size by Country (2016-2021) 6.4.2 North America CIS Insulin Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe CIS Insulin Market Size (2016-2027) 7.2 Europe CIS Insulin Market Size by Type 7.2.1 Europe CIS Insulin Market Size by Type (2016-2021) 7.2.2 Europe CIS Insulin Market Size by Type (2022-2027) 7.2.3 Europe CIS Insulin Market Size by Type (2016-2027) 7.3 Europe CIS Insulin Market Size by Application 7.3.1 Europe CIS Insulin Market Size by Application (2016-2021) 7.3.2 Europe CIS Insulin Market Size by Application (2022-2027) 7.3.3 Europe CIS Insulin Market Size by Application (2016-2027) 7.4 Europe CIS Insulin Market Size by Country 7.4.1 Europe CIS Insulin Market Size by Country (2016-2021) 7.4.2 Europe CIS Insulin Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific CIS Insulin Market Size (2016-2027) 8.2 Asia-Pacific CIS Insulin Market Size by Type 8.2.1 Asia-Pacific CIS Insulin Market Size by Type (2016-2021) 8.2.2 Asia-Pacific CIS Insulin Market Size by Type (2022-2027) 8.2.3 Asia-Pacific CIS Insulin Market Size by Type (2016-2027) 8.3 Asia-Pacific CIS Insulin Market Size by Application 8.3.1 Asia-Pacific CIS Insulin Market Size by Application (2016-2021) 8.3.2 Asia-Pacific CIS Insulin Market Size by Application (2022-2027) 8.3.3 Asia-Pacific CIS Insulin Market Size by Application (2016-2027) 8.4 Asia-Pacific CIS Insulin Market Size by Region 8.4.1 Asia-Pacific CIS Insulin Market Size by Region (2016-2021) 8.4.2 Asia-Pacific CIS Insulin Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America CIS Insulin Market Size (2016-2027) 9.2 Latin America CIS Insulin Market Size by Type 9.2.1 Latin America CIS Insulin Market Size by Type (2016-2021) 9.2.2 Latin America CIS Insulin Market Size by Type (2022-2027) 9.2.3 Latin America CIS Insulin Market Size by Type (2016-2027) 9.3 Latin America CIS Insulin Market Size by Application 9.3.1 Latin America CIS Insulin Market Size by Application (2016-2021) 9.3.2 Latin America CIS Insulin Market Size by Application (2022-2027) 9.3.3 Latin America CIS Insulin Market Size by Application (2016-2027) 9.4 Latin America CIS Insulin Market Size by Country 9.4.1 Latin America CIS Insulin Market Size by Country (2016-2021) 9.4.2 Latin America CIS Insulin Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa CIS Insulin Market Size (2016-2027) 10.2 Middle East & Africa CIS Insulin Market Size by Type 10.2.1 Middle East & Africa CIS Insulin Market Size by Type (2016-2021) 10.2.2 Middle East & Africa CIS Insulin Market Size by Type (2022-2027) 10.2.3 Middle East & Africa CIS Insulin Market Size by Type (2016-2027) 10.3 Middle East & Africa CIS Insulin Market Size by Application 10.3.1 Middle East & Africa CIS Insulin Market Size by Application (2016-2021) 10.3.2 Middle East & Africa CIS Insulin Market Size by Application (2022-2027) 10.3.3 Middle East & Africa CIS Insulin Market Size by Application (2016-2027) 10.4 Middle East & Africa CIS Insulin Market Size by Country 10.4.1 Middle East & Africa CIS Insulin Market Size by Country (2016-2021) 10.4.2 Middle East & Africa CIS Insulin Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Eli Lilly 11.1.1 Eli Lilly Company Details 11.1.2 Eli Lilly Business Overview 11.1.3 Eli Lilly CIS Insulin Introduction 11.1.4 Eli Lilly Revenue in CIS Insulin Business (2016-2021) 11.1.5 Eli Lilly Recent Development 11.2 Novo Nordisk 11.2.1 Novo Nordisk Company Details 11.2.2 Novo Nordisk Business Overview 11.2.3 Novo Nordisk CIS Insulin Introduction 11.2.4 Novo Nordisk Revenue in CIS Insulin Business (2016-2021) 11.2.5 Novo Nordisk Recent Development 11.3 Takeda Pharmaceuticals 11.3.1 Takeda Pharmaceuticals Company Details 11.3.2 Takeda Pharmaceuticals Business Overview 11.3.3 Takeda Pharmaceuticals CIS Insulin Introduction 11.3.4 Takeda Pharmaceuticals Revenue in CIS Insulin Business (2016-2021) 11.3.5 Takeda Pharmaceuticals Recent Development 11.4 Sanofi Aventis 11.4.1 Sanofi Aventis Company Details 11.4.2 Sanofi Aventis Business Overview 11.4.3 Sanofi Aventis CIS Insulin Introduction 11.4.4 Sanofi Aventis Revenue in CIS Insulin Business (2016-2021) 11.4.5 Sanofi Aventis Recent Development 11.5 Nanjing Xinbai Pharmaceutical 11.5.1 Nanjing Xinbai Pharmaceutical Company Details 11.5.2 Nanjing Xinbai Pharmaceutical Business Overview 11.5.3 Nanjing Xinbai Pharmaceutical CIS Insulin Introduction 11.5.4 Nanjing Xinbai Pharmaceutical Revenue in CIS Insulin Business (2016-2021) 11.5.5 Nanjing Xinbai Pharmaceutical Recent Development 11.6 Oramed Pharmaceuticals 11.6.1 Oramed Pharmaceuticals Company Details 11.6.2 Oramed Pharmaceuticals Business Overview 11.6.3 Oramed Pharmaceuticals CIS Insulin Introduction 11.6.4 Oramed Pharmaceuticals Revenue in CIS Insulin Business (2016-2021) 11.6.5 Oramed Pharmaceuticals Recent Development 11.7 Merck 11.7.1 Merck Company Details 11.7.2 Merck Business Overview 11.7.3 Merck CIS Insulin Introduction 11.7.4 Merck Revenue in CIS Insulin Business (2016-2021) 11.7.5 Merck Recent Development 11.8 Boehringer Ingelheim 11.8.1 Boehringer Ingelheim Company Details 11.8.2 Boehringer Ingelheim Business Overview 11.8.3 Boehringer Ingelheim CIS Insulin Introduction 11.8.4 Boehringer Ingelheim Revenue in CIS Insulin Business (2016-2021) 11.8.5 Boehringer Ingelheim Recent Development 11.9 Biocon 11.9.1 Biocon Company Details 11.9.2 Biocon Business Overview 11.9.3 Biocon CIS Insulin Introduction 11.9.4 Biocon Revenue in CIS Insulin Business (2016-2021) 11.9.5 Biocon Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global CIS Insulin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Long-Acting Analog Table 3. Key Players of Rapid Acting Analog Table 4. Key Players of Premixed Analog Table 5. Key Players of Intermediate Insulin Table 6. Key Players of Short Acting Insulin Table 7. Key Players of Premixed Insulin Table 8. Global CIS Insulin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global CIS Insulin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global CIS Insulin Market Size by Regions (2016-2021) & (US$ Million) Table 11. Global CIS Insulin Market Share by Regions (2016-2021) Table 12. Global CIS Insulin Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 13. Global CIS Insulin Market Share by Regions (2022-2027) Table 14. CIS Insulin Market Trends Table 15. CIS Insulin Market Drivers Table 16. CIS Insulin Market Challenges Table 17. CIS Insulin Market Restraints Table 18. Global CIS Insulin Revenue by Players (2016-2021) & (US$ Million) Table 19. Global CIS Insulin Market Share by Players (2016-2021) Table 20. Global Top CIS Insulin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CIS Insulin as of 2020) Table 21. Ranking of Global Top CIS Insulin Companies by Revenue (US$ Million) in 2020 Table 22. Global 5 Largest Players Market Share by CIS Insulin Revenue (CR5 and HHI) & (2016-2021) Table 23. Key Players Headquarters and Area Served Table 24. Key Players CIS Insulin Product Solution and Service Table 25. Date of Enter into CIS Insulin Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global CIS Insulin Market Size by Type (2016-2021) (US$ Million) Table 28. Global CIS Insulin Revenue Market Share by Type (2016-2021) Table 29. Global CIS Insulin Forecasted Market Size by Type (2022-2027) (US$ Million) Table 30. Global CIS Insulin Revenue Market Share by Type (2022-2027) & (US$ Million) Table 31. Global CIS Insulin Market Size Share by Application (2016-2021) & (US$ Million) Table 32. Global CIS Insulin Revenue Market Share by Application (2016-2021) Table 33. Global CIS Insulin Forecasted Market Size by Application (2022-2027) (US$ Million) Table 34. Global CIS Insulin Revenue Market Share by Application (2022-2027) & (US$ Million) Table 35. North America CIS Insulin Market Size by Type (2016-2021) (US$ Million) Table 36. North America CIS Insulin Market Size by Type (2022-2027) & (US$ Million) Table 37. North America CIS Insulin Market Size by Application (2016-2021) (US$ Million) Table 38. North America CIS Insulin Market Size by Application (2022-2027) & (US$ Million) Table 39. North America CIS Insulin Market Size by Country (2016-2021) & (US$ Million) Table 40. North America CIS Insulin Market Size by Country (2022-2027) & (US$ Million) Table 41. Europe CIS Insulin Market Size by Type (2016-2021) (US$ Million) Table 42. Europe CIS Insulin Market Size by Type (2022-2027) & (US$ Million) Table 43. Europe CIS Insulin Market Size by Application (2016-2021) (US$ Million) Table 44. Europe CIS Insulin Market Size by Application (2022-2027) & (US$ Million) Table 45. Europe CIS Insulin Market Size by Country (2016-2021) & (US$ Million) Table 46. Europe CIS Insulin Market Size by Country (2022-2027) & (US$ Million) Table 47. Asia-Pacific CIS Insulin Market Size by Type (2016-2021) (US$ Million) Table 48. Asia-Pacific CIS Insulin Market Size by Type (2022-2027) & (US$ Million) Table 49. Asia-Pacific CIS Insulin Market Size by Application (2016-2021) (US$ Million) Table 50. Asia-Pacific CIS Insulin Market Size by Application (2022-2027) & (US$ Million) Table 51. Asia-Pacific CIS Insulin Market Size by Region (2016-2021) & (US$ Million) Table 52. Asia-Pacific CIS Insulin Market Size by Region (2022-2027) & (US$ Million) Table 53. Latin America CIS Insulin Market Size by Type (2016-2021) (US$ Million) Table 54. Latin America CIS Insulin Market Size by Type (2022-2027) & (US$ Million) Table 55. Latin America CIS Insulin Market Size by Application (2016-2021) (US$ Million) Table 56. Latin America CIS Insulin Market Size by Application (2022-2027) & (US$ Million) Table 57. Latin America CIS Insulin Market Size by Country (2016-2021) & (US$ Million) Table 58. Latin America CIS Insulin Market Size by Country (2022-2027) & (US$ Million) Table 59. Middle East & Africa CIS Insulin Market Size by Type (2016-2021) (US$ Million) Table 60. Middle East & Africa CIS Insulin Market Size by Type (2022-2027) & (US$ Million) Table 61. Middle East & Africa CIS Insulin Market Size by Application (2016-2021) (US$ Million) Table 62. Middle East & Africa CIS Insulin Market Size by Application (2022-2027) & (US$ Million) Table 63. Middle East & Africa CIS Insulin Market Size by Country (2016-2021) & (US$ Million) Table 64. Middle East & Africa CIS Insulin Market Size by Country (2022-2027) & (US$ Million) Table 65. Eli Lilly Company Details Table 66. Eli Lilly Business Overview Table 67. Eli Lilly CIS Insulin Product Table 68. Eli Lilly Revenue in CIS Insulin Business (2016-2021) & (US$ Million) Table 69. Eli Lilly Recent Development Table 70. Novo Nordisk Company Details Table 71. Novo Nordisk Business Overview Table 72. Novo Nordisk CIS Insulin Product Table 73. Novo Nordisk Revenue in CIS Insulin Business (2016-2021) & (US$ Million) Table 74. Novo Nordisk Recent Development Table 75. Takeda Pharmaceuticals Company Details Table 76. Takeda Pharmaceuticals Business Overview Table 77. Takeda Pharmaceuticals CIS Insulin Product Table 78. Takeda Pharmaceuticals Revenue in CIS Insulin Business (2016-2021) & (US$ Million) Table 79. Takeda Pharmaceuticals Recent Development Table 80. Sanofi Aventis Company Details Table 81. Sanofi Aventis Business Overview Table 82. Sanofi Aventis CIS Insulin Product Table 83. Sanofi Aventis Revenue in CIS Insulin Business (2016-2021) & (US$ Million) Table 84. Sanofi Aventis Recent Development Table 85. Nanjing Xinbai Pharmaceutical Company Details Table 86. Nanjing Xinbai Pharmaceutical Business Overview Table 87. Nanjing Xinbai Pharmaceutical CIS Insulin Product Table 88. Nanjing Xinbai Pharmaceutical Revenue in CIS Insulin Business (2016-2021) & (US$ Million) Table 89. Nanjing Xinbai Pharmaceutical Recent Development Table 90. Oramed Pharmaceuticals Company Details Table 91. Oramed Pharmaceuticals Business Overview Table 92. Oramed Pharmaceuticals CIS Insulin Product Table 93. Oramed Pharmaceuticals Revenue in CIS Insulin Business (2016-2021) & (US$ Million) Table 94. Oramed Pharmaceuticals Recent Development Table 95. Merck Company Details Table 96. Merck Business Overview Table 97. Merck CIS Insulin Product Table 98. Merck Revenue in CIS Insulin Business (2016-2021) & (US$ Million) Table 99. Merck Recent Development Table 100. Boehringer Ingelheim Company Details Table 101. Boehringer Ingelheim Business Overview Table 102. Boehringer Ingelheim Revenue in CIS Insulin Business (2016-2021) & (US$ Million) Table 103. Boehringer Ingelheim Recent Development Table 104. Biocon Company Details Table 105. Biocon Business Overview Table 106. Biocon CIS Insulin Product Table 107. Biocon Revenue in CIS Insulin Business (2016-2021) & (US$ Million) Table 108. Biocon Recent Development Table 109. Research Programs/Design for This Report Table 110. Key Data Information from Secondary Sources Table 111. Key Data Information from Primary Sources List of Figures Figure 1. Global CIS Insulin Market Share by Type: 2020 VS 2027 Figure 2. Long-Acting Analog Features Figure 3. Rapid Acting Analog Features Figure 4. Premixed Analog Features Figure 5. Intermediate Insulin Features Figure 6. Short Acting Insulin Features Figure 7. Premixed Insulin Features Figure 8. Global CIS Insulin Market Share by Application: 2020 VS 2027 Figure 9. Type I and Other Diabetes Case Studies Figure 10. Type II Diabetes Case Studies Figure 11. CIS Insulin Report Years Considered Figure 12. Global CIS Insulin Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global CIS Insulin Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global CIS Insulin Market Share by Regions: 2020 VS 2027 Figure 15. Global CIS Insulin Market Share by Regions (2022-2027) Figure 16. Global CIS Insulin Market Share by Players in 2020 Figure 17. Global Top CIS Insulin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CIS Insulin as of 2020 Figure 18. The Top 10 and 5 Players Market Share by CIS Insulin Revenue in 2020 Figure 19. Global CIS Insulin Revenue Market Share by Type (2016-2021) Figure 20. Global CIS Insulin Revenue Market Share by Type (2022-2027) Figure 21. North America CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America CIS Insulin Market Share by Type (2016-2027) Figure 23. North America CIS Insulin Market Share by Application (2016-2027) Figure 24. North America CIS Insulin Market Share by Country (2016-2027) Figure 25. United States CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe CIS Insulin Market Share by Type (2016-2027) Figure 29. Europe CIS Insulin Market Share by Application (2016-2027) Figure 30. Europe CIS Insulin Market Share by Country (2016-2027) Figure 31. Germany CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific CIS Insulin Market Share by Type (2016-2027) Figure 39. Asia-Pacific CIS Insulin Market Share by Application (2016-2027) Figure 40. Asia-Pacific CIS Insulin Market Share by Region (2016-2027) Figure 41. China CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America CIS Insulin Market Share by Type (2016-2027) Figure 49. Latin America CIS Insulin Market Share by Application (2016-2027) Figure 50. Latin America CIS Insulin Market Share by Country (2016-2027) Figure 51. Mexico CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa CIS Insulin Market Share by Type (2016-2027) Figure 55. Middle East & Africa CIS Insulin Market Share by Application (2016-2027) Figure 56. Middle East & Africa CIS Insulin Market Share by Country (2016-2027) Figure 57. Turkey CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Eli Lilly Revenue Growth Rate in CIS Insulin Business (2016-2021) Figure 61. Novo Nordisk Revenue Growth Rate in CIS Insulin Business (2016-2021) Figure 62. Takeda Pharmaceuticals Revenue Growth Rate in CIS Insulin Business (2016-2021) Figure 63. Sanofi Aventis Revenue Growth Rate in CIS Insulin Business (2016-2021) Figure 64. Nanjing Xinbai Pharmaceutical Revenue Growth Rate in CIS Insulin Business (2016-2021) Figure 65. Oramed Pharmaceuticals Revenue Growth Rate in CIS Insulin Business (2016-2021) Figure 66. Merck Revenue Growth Rate in CIS Insulin Business (2016-2021) Figure 67. Boehringer Ingelheim Revenue Growth Rate in CIS Insulin Business (2016-2021) Figure 68. Biocon Revenue Growth Rate in CIS Insulin Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Eli Lilly Novo Nordisk Takeda Pharmaceuticals Sanofi Aventis Nanjing Xinbai Pharmaceutical Oramed Pharmaceuticals Merck Boehringer Ingelheim Biocon